Budd‐Chiari syndrome on background of JAK2V617F mutation with no hematologic abnormalities

Abstract

Abstract Whenever considering idiopathic Budd‐Chiari syndrome, consider the possibility of JAK2 mutation even if clinical parameters are within normal range.

Keywords

• Bud‐Chiari syndrome
• hepatic vein thrombosis
• JAK 2 mutation
• myeloproliferative disease